Uptravi 200 mcg
Uptravi 200 mcg is a medicine authorised by Swissmedic under authorisation number 65643. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 August 2016 and the authorisation is valid without a time limit. ATC code B01AC27 places the medicine in the group Antithrombotic agents.
| Authorisation number | 65643 |
|---|---|
| Name | Uptravi 200 mcg |
| Full name | Uptravi 200 mcg, Filmtabletten |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AC27 |
| First authorisation | 15 August 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Uptravi 200 mcg, Filmtabletten | B | 15 August 2016 |
| 2 | Uptravi 400 mcg, Filmtabletten | B | 15 August 2016 |
| 3 | Uptravi 600 mcg, Filmtabletten | B | 15 August 2016 |
| 4 | Uptravi 800 mcg, Filmtabletten | B | 15 August 2016 |
| 5 | Uptravi 1000 mcg, Filmtabletten | B | 15 August 2016 |
| 6 | Uptravi 1200 mcg, Filmtabletten | B | 15 August 2016 |
| 7 | Uptravi 1400 mcg, Filmtabletten | B | 15 August 2016 |
| 8 | Uptravi 1600 mcg, Filmtabletten | B | 15 August 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 2 | 140 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 3 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 4 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 5 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 6 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 7 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 8 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
| 9 | 60 | Tablette(n) | B01AC27 | 02.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Uptravi 200 mcg authorised in Switzerland?
Yes. Uptravi 200 mcg is authorised by Swissmedic under authorisation number 65643, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Uptravi 200 mcg have?
Uptravi 200 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Uptravi 200 mcg?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.